Ep. 111 - Chuck Melendi Unveils the Truth Behind Big Pharma - Re-release
Drug prices soar, patient bills spike and everyone blames Big Pharma, but what if the real power players sit in the shadows behind your pharmacy counter? In the re-release of this foundational episode of Working Healthcare, Meredith Hirsh invites Chuck Melendi, founder of the Disruptive Dialogue podcast and veteran Johnson & Johnson insider, to walk straight into the fire and unpack the truth behind the industry’s most polarizing debates.
Chuck uses clear, punchy stories and hard numbers to show how “Big Pharma” no longer stands as the biggest giant in healthcare, then compares drug manufacturer revenue to the colossal income of insurers and PBMs that quietly control formularies, rebates and patient access. He explains how direct-to-consumer advertising evolves, why TV spots drive sales and why he still argues for unbranded education that keeps the conversation between physician and patient. Meredith presses him on drug pricing, and Chuck responds with an insider’s view of transparency reports, R&D budgets and the delicate balance between profit, innovation and public responsibility.
The episode then dives into the rebate game, formulary battles and the brutal leverage PBMs hold over both manufacturers and clinics, all in language that clinicians, patients and advocates can follow. Chuck shares vivid moments from decades of account management, including the tug-of-war between safety data, patient services and the raw economics that dictate which medications stay on a plan. He tells the personal story behind his decision to leave J&J, describes himself as “too knowledgeable to stay silent” and why he launched a mission-driven effort to disrupt the system through consulting, speaking and podcasting. Meredith and Chuck close with a bold wish: break up publicly traded insurers and PBMs and restore a healthcare landscape that serves patients instead of quarterly earnings.
If you want a candid, experienced voice to guide you through the real forces behind drug prices, PBMs and Big Pharma’s reputation, listen in to this episode of Working Healthcare and share it with someone who navigates those pressures every day.
Contact Chuck:
LinkedIn: @chuckmelendi [https://www.linkedin.com/in/chuckmelendi/]
Website: disruptivedialogue.org/meet-chuck [https://www.disruptivedialogue.org/meet-chuck]
Discruptive Dialogue podcast: Disruptive Dialogue with Chuck Melendi [https://podcasts.apple.com/us/podcast/disruptive-dialogue-with-chuck-melendi/id1809415150]
Instagram: @chuckmelendi [https://www.instagram.com/chuckmelendi/]
Facebook: facebook.com/cmelendijr [https://www.facebook.com/cmelendijr/]
YouTube: @DisruptiveDialoguePodcast [https://www.youtube.com/@DisruptiveDialoguePodcast]
Contact Meredith:
Website: meredithhirsh.com [https://www.meredithhirsh.com/]
Instagram: @workinghealthcare [https://www.instagram.com/workinghealthcare/]
Facebook: WorkingHealthcare [https://www.facebook.com/workinghealthcarepodcast]
LinkedIn: @meredithfhirsh [https://www.linkedin.com/in/meredithfhirsh/]
YouTube: @WorkingHealthcare [https://www.youtube.com/@WorkingHealthcare]
Kommentarer
0Vær den første til å kommentere
Registrer deg nå og bli medlem av Working Healthcare sitt community!